Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion - Concepedia

Concepedia

Publication | Closed Access

Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion

33

Citations

4

References

1998

Year

R. Thödtmann, Andreas Hüttmann, W.E. Berdel, C. Manegold, H.H. Fiebig, A. Kaeser-Fróhlich, K. Burk, A.-R. Hanauske

Investigational New Drugs

MedicineIntravenous Short InfusionClinical PharmacologyPharmacokinetic TrialPharmacotherapyPodophyllotoxin Derivative Nk611PharmacologyPharmacokinetics

References

	Year	Citations

Page 1